Skip to main content
. 2019 Jan;60(1):134–146. doi: 10.1167/iovs.18-24878

Table 2.

Comparison of Clinical Variables in Glaucoma/XFS Patients and Control Subjects

Cohort
Control
Glaucoma
P Value
Cohort 1 and 2 (N = 30) (N = 27)
 Age (years) 73 ± 5 79 ± 7 0.001
 Max IOP 18 ± 3 22 ± 8 0.015
 Sex (female) 24 (80%) 27 (100%) 0.025
Cohort 1 (NY) (N = 8) (N = 11)
 Age (years) 72 ± 5 74 ± 6 0.44
 Max IOP 19 ± 4 23 ± 8 0.09
 Sex (female) 8 (100%) 11 (100%) 1
Cohort 2 (Japan) (N = 22) (N = 16)
 Age (years) 74 ± 5 82 ± 6 0.00003
 Max IOP 18 ± 3 21 ± 7 0.15
 Sex (female) 16 (73%) 16 (100%) 0.03

T-tests were employed to compare age and Max IOP between glaucoma and control subjects. Gender distribution (%) was evaluated with a Fisher's exact test.